Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Biree Andemariam

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Annals of Hematology|May 8, 2020
A study of the geographic distribution and associated risk factors of leg ulcers within an international cohort of sickle cell disease patients: the CASiRe group analysisCharles Antwi-Boasiako, Biree Andemariam, Raffaella Colombatti, et al.
Journal of Women'S Health (2002)|November 27, 2023
Pain Frequency and Health Care Utilization Patterns in Women with Sickle Cell Disease Experiencing Menstruation-Associated Pain CrisesCatherine Segbefia, Jillian Campbell, Immacolata Tartaglione, et al.
Blood Cells, Molecules & Diseases|January 5, 2021
Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohortImmacolata Tartaglione, Crawford Strunk, Charles Antwi-Boasiako, et al.
Pain Medicine (Malden, Mass.)|February 15, 2022
Pain Burden in the CASiRe International Cohort of Sickle Cell Patients: United States and GhanaWilliam T Zempsky, Mary Yanaros, Mohammed Sayeem, et al.
Journal of Sickle Cell Disease|December 15, 2025
International variations in body mass index within the CASiRe global cohort of sickle cell disease patientsCrawford Strunk, Angela Rivers, Catherine Segbefia, et al.
Blood Cells, Molecules & Diseases|September 26, 2021
Global geographic differences in healthcare utilization for sickle cell disease pain crises in the CASiRe cohortCrawford Strunk, Immacolata Tartaglione, Connie M Piccone, et al.
The Lancet. Haematology|December 7, 2024
Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trialModupe Idowu, Lucas Otieno, Bogdan Dumitriu, et al.
The Lancet. Haematology|July 14, 2023
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology CommissionFrédéric B Piel, David C Rees, Michael R DeBaun, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Annals of Hematology|May 8, 2020
A study of the geographic distribution and associated risk factors of leg ulcers within an international cohort of sickle cell disease patients: the CASiRe group analysisCharles Antwi-Boasiako, Biree Andemariam, Raffaella Colombatti, et al.
Journal of Women'S Health (2002)|November 27, 2023
Pain Frequency and Health Care Utilization Patterns in Women with Sickle Cell Disease Experiencing Menstruation-Associated Pain CrisesCatherine Segbefia, Jillian Campbell, Immacolata Tartaglione, et al.
Blood Cells, Molecules & Diseases|January 5, 2021
Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohortImmacolata Tartaglione, Crawford Strunk, Charles Antwi-Boasiako, et al.
Pain Medicine (Malden, Mass.)|February 15, 2022
Pain Burden in the CASiRe International Cohort of Sickle Cell Patients: United States and GhanaWilliam T Zempsky, Mary Yanaros, Mohammed Sayeem, et al.
Journal of Sickle Cell Disease|December 15, 2025
International variations in body mass index within the CASiRe global cohort of sickle cell disease patientsCrawford Strunk, Angela Rivers, Catherine Segbefia, et al.
Blood Cells, Molecules & Diseases|September 26, 2021
Global geographic differences in healthcare utilization for sickle cell disease pain crises in the CASiRe cohortCrawford Strunk, Immacolata Tartaglione, Connie M Piccone, et al.
The Lancet. Haematology|December 7, 2024
Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trialModupe Idowu, Lucas Otieno, Bogdan Dumitriu, et al.
The Lancet. Haematology|July 14, 2023
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology CommissionFrédéric B Piel, David C Rees, Michael R DeBaun, et al.
Pageof 7